Novel Therapeutics for the Treatment and Prevention of Avian Influenza
Background:
The National Cancer Institute is
seeking statements of capability or interest from parties
interested in collaborative research to further develop, evaluate,
or commercialize cyanovirin-N for use against H5N1 influenza. The
technology is also available (more...)
(Full Text)
Novel Cancer Immunotherapy Approaches For The Treatment And Prevention Of Cancer
Background:
The National Cancer Institute's Laboratory of
Tumor Immunology and Biology is seeking statements of capability or
interest from parties interested in collaborative research to
further develop, evaluate, or commercialize cancer immunotherapy
using costimulation. See (more...)
(Full Text)
Method To Inactivate Viruses For Vaccine Development
Background:
The National Cancer Institute's Nanobiology Program is seeking
statements of capability or interest from parties interested in
collaborative research to further develop, evaluate, or
commercialize the use of hydrophobic crosslinkers for vaccine
development using (more...)
(Full Text)
Method For Effiecient Delivery Of Proteins Into Cells
Background:
The National Cancer Institute's Protein Expression Laboratory is
seeking statements of capability or interest from parties
interested in collaborative research to further develop, evaluate,
or commercialize methods for delivery of proteins using virus-like
particles.
Proteins (more...)
(Full Text)
Method For Effiecient Delivery Of Proteins Into Cells
Therapeutics To Treat Ocular Diseases
Monoclonal Antibodies Against B-Cell Chronic Lymphocytic Leukemia (B-CLL) Tumors
TTC maintains an e-mail service to notify you of new Collaborative Opportunities. If you would like to receive these emails, please sign up below. If you'd like to unsubscribe you can use this form as well.